Logo image of MIST

MILESTONE PHARMACEUTICALS IN (MIST) Stock Earnings & Estimates

NASDAQ:MIST - CA59935V1076 - Common Stock

1.84 USD
+0.03 (+1.66%)
Last: 8/29/2025, 8:00:01 PM
1.8399 USD
0 (-0.01%)
After Hours: 8/29/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MIST revenue by date.MIST revenue by date.
15M5M
-66.67%
1M
-80.00%

-100.00%
32.946M65.892M
100.00%
157.44M
138.94%
235.98M
49.89%
314.06M
33.09%
298.35M
-5.00%
448.6M
50.36%
EBITDA
YoY % growth
MIST ebitda by date.MIST ebitda by date.
-42.98M
15.08%
-59.55M
-38.55%
-61.006M
-2.45%
-38.76M
31.16%
-20.4M
51.43%
-61.914M
-203.50%
-58.854M
4.94%
-13.158M
77.64%
65.586M
598.45%
158.3M
141.36%
N/AN/A
EBIT
YoY % growth
MIST ebit by date.MIST ebit by date.
-43.07M
15.07%
-59.64M
-38.47%
-61.098M
-2.44%
-41.018M
31.09%
-66.594M
-58.17%
-88.795M
-33.34%
-97.852M
-10.20%
-2.754M
97.19%
40.494M
1,570.37%
112.51M
177.84%
130.87M
16.32%
N/A
Operating Margin
MIST operating margin by date.MIST operating margin by date.
-287.13%-1,192.80%-6,109.80%N/AN/A-269.52%-148.50%-1.75%17.16%35.82%43.86%N/A
EPS
YoY % growth
MIST eps by date.MIST eps by date.
-1.02
41.04%
-1.37
-34.31%
-1.39
-1.46%
-0.63
50.43%
-0.87
-25.83%
-1.05
-21.18%
-1.20
-14.56%
-0.06
95.34%
0.34
700.00%
0.88
162.12%
1.61
82.66%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.16
-14.75%
-0.23
-17.89%
-0.28
10.07%
-0.26
-27.50%
-0.23
-46.03%
-0.26
-8.70%
Revenue
Q2Q % growth
510K1.836M1.734M3.774M
EBITDA
Q2Q % growth
-19.992M
-109.63%
-21.318M
-74.12%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-13.49M
-40.28%
-19.355M
-56.74%
-17.799M
13.27%
-18.886M
-50.72%
-23.653M
-75.34%
-25.598M
-32.26%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.20
-42.86%
-0.18-0.02-10.47%
Q1 2025
Q2Q % growth
-0.31
-47.62%
-0.19-0.12-64.28%
Q4 2024
Q2Q % growth
-0.20
37.81%
-0.16-0.04-27.93%
Q3 2024
Q2Q % growth
-0.14
60.00%
-0.170.0315.96%
Q2 2024
Q2Q % growth
-0.14
62.16%
-0.190.0527.76%
Q1 2024
Q2Q % growth
-0.21
40.00%
-0.270.0620.81%
Q4 2023
Q2Q % growth
-0.32
-3.23%
-0.320.00-0.39%
Q3 2023
Q2Q % growth
-0.35
-2.94%
-0.390.0410.17%
Q2 2023
Q2Q % growth
-0.37
5.13%
-0.390.026.02%
Q1 2023
Q2Q % growth
-0.35
-6.06%
-0.410.0613.78%
Q4 2022
Q2Q % growth
-0.31
22.50%
-0.340.039.28%
Q3 2022
Q2Q % growth
-0.34 -0.420.0818.30%
Q2 2022
Q2Q % growth
-0.39
-2,050.00%
-0.37-0.02-6.21%
Q1 2022
Q2Q % growth
-0.33
-10.00%
-0.400.0717.04%
Q4 2021
Q2Q % growth
-0.40
-207.69%
-0.37-0.03-7.74%
Q3 2021
Q2Q % growth
-0.34
15.00%
-0.390.0513.19%
Q2 2021
Q2Q % growth
0.02
103.77%
-0.270.29107.48%
Q1 2021
Q2Q % growth
-0.30
55.22%
-0.330.0310.33%
Q4 2020
Q2Q % growth
-0.13
79.37%
-0.410.2868.61%
Q3 2020
Q2Q % growth
-0.40
23.08%
-0.500.1019.97%
Q2 2020
Q2Q % growth
-0.53
49.04%
-0.48-0.05-11.15%
Q1 2020
Q2Q % growth
-0.67 -0.760.0911.53%
Q4 2019
Q2Q % growth
-0.63 -0.53-0.10-19.93%
Q3 2019
Q2Q % growth
-0.52 -0.49-0.03-5.11%
Q2 2019
Q2Q % growth
-1.04 -0.48-0.56-114.65%
MIST Yearly EPS VS EstimatesMIST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth

-100.00%
%
Q3 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth
3.5M 892.5K2.608M292.16%
Q2 2022
Q2Q % growth

-100.00%
%
Q2 2021
Q2Q % growth
15M 3.06M11.94M390.20%
MIST Yearly Revenue VS EstimatesMIST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS3.08% 43.75% -4.08% 14.14%
RevenueN/A -100% N/A N/A